FYCOMPA Strength
Active ingredient(s) See footnote 8 : Strength PERAMPANEL : 6.0 MG · DIN 02404532 · EISAI LIMITED 6925 Century Ave, Suite 701 Mississauga Ontario Canada L5N 7K2
Health Canada status: MARKETED
What is FYCOMPA?
FYCOMPA Strength contains Active ingredient(s) See footnote 8 : Strength PERAMPANEL : 6.0 MG. It is listed in the Health Canada Drug Product Database under DIN 02404532, held by EISAI LIMITED 6925 Century Ave, Suite 701 Mississauga Ontario Canada L5N 7K2, supplied as Tablet for Oral administration. Health Canada currently lists it as marketed, status dated 19-Jun-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FYCOMPA used for?
FYCOMPA (perampanel) tablets are indicated as adjunctive therapy in the management of partial-onset seizures in patients 7 years of age and older who are not satisfactorily controlled with conventional therapy. It is also indicated as adjunctive therapy in the management of primary generalized tonic-clonic (PGTC) seizures in patients 12 years of age and older with epilepsy, who are not satisfactorily controlled with conventional therapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02404532 |
|---|---|
| Brand name | FYCOMPA |
| Generic / active ingredient | Active ingredient(s) See footnote 8 : Strength PERAMPANEL : 6.0 MG |
| Manufacturer | EISAI LIMITED 6925 Century Ave, Suite 701 Mississauga Ontario Canada L5N 7K2 |
| Strength | Strength |
| Dosage form | Tablet |
| Route of administration | Oral |
| Schedule | PRESCRIPTION |
| ATC code | N03AX22 PERAMPANEL |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 19-Jun-2013 |
| Original market date | 2013-06-19 |
How is it stored and handled?
null
How is it supplied?
HDPE bottles of 30 and 90 tablets, and as blisters (PVC/aluminum) in packs of 7 tablets (for 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg)
What can be used instead?
Other Canadian products sharing ATC code N03AX22 PERAMPANEL. 12 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FYCOMPA | 10.0 MG | TABLET | EISAI LIMITED | MARKETED | DIN 02404559 |
| FYCOMPA | 12.0 MG | TABLET | EISAI LIMITED | MARKETED | DIN 02404567 |
| FYCOMPA | 8.0 MG | TABLET | EISAI LIMITED | MARKETED | DIN 02404540 |
| FYCOMPA | Strength | Tablet | EISAI LIMITED 6925 Century Ave, Suite 701 Mississauga Ontario Canada L5N 7K2 | MARKETED | DIN 02404524 |
| FYCOMPA | Strength | Tablet | EISAI LIMITED 6925 Century Ave, Suite 701 Mississauga Ontario Canada L5N 7K2 | MARKETED | DIN 02404516 |
| TARO-PERAMPANEL | 10 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED | DIN 02522675 |
| TARO-PERAMPANEL | 12 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED | DIN 02522683 |
| TARO-PERAMPANEL | 2 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED | DIN 02522632 |
| TARO-PERAMPANEL | 4 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED | DIN 02522640 |
| TARO-PERAMPANEL | 6 MG | TABLET | TARO PHARMACEUTICALS INC | MARKETED | DIN 02522659 |
Who else supplies PERAMPANEL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PERAMPANEL appears in 114 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.